Long-term prosthetic-associated subclinical thrombotic events evaluation by cardiac CTA after transcatheter aortic valve implantation: incidence and outcomes.
Qijing Zhou, Jiaqi Wen, Qifeng Zhu...
https://pubmed.ncbi.nlm.nih.gov/38816554/Actively Recruiting
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2021-07-15
2000
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research aims to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese patients with symptomatic aortic stenosis or severe aortic regurgitation. The study is designed as a Phase 4 interventional trial conducted by the Second Affiliated Hospital, School of Medicine, Zhejiang University. Participants undergo physical exams and screening to confirm their condition and eligibility for the procedure. Those qualifying receive transcatheter aortic valve replacement, which is the only treatment approach assessed in this study. Throughout the study, patients are monitored for various health outcomes including death from any cause within one year, and other cardiovascular events such as stroke, myocardial infarction, and device success tracked over up to ten years. Patients must comply with follow-up visits at the investigational site to assess their condition and treatment effects over time.
CONDITIONS
Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
X
Xianbao Liu, MD
J
Jian-an Wang, MD,PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Procedure and immediate hospital stay
Participants undergo transcatheter aortic valve replacement to treat symptomatic aortic stenosis or severe aortic regurgitation.
1 procedure visit
Duration - Up to 10 years
Participants return for follow-up visits to monitor health outcomes including survival and complications after the procedure.
Regular visits at 30 days, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years, and 10 years
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Qijing Zhou, Jiaqi Wen, Qifeng Zhu...
https://pubmed.ncbi.nlm.nih.gov/38816554/Jiaqi Fan, Jun Chen, Gangjie Zhu...
https://pubmed.ncbi.nlm.nih.gov/39080364/Jiaqi Fan, Xian Fang, Chunhui Liu...
https://pubmed.ncbi.nlm.nih.gov/33243378/Po Hu, Han Chen, Li-Han Wang...
https://pubmed.ncbi.nlm.nih.gov/35413789/Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor